BAHRAIN Trends and Developments Contributed by: Noor Al Rayes, Bradley Price, Mohamed Al Sari and Raghad Al Matrook, Al Tamimi & Company
Merger control dynamics and unwinding risks Merger control represents one of the most immediate antitrust compliance challenges for corporate transac - tions in Bahrain. The Competition Law requires man - datory prior notification and clearance for any eco - nomic concentration that meets specified statutory thresholds. An economic concentration encompasses full mergers, stock or asset acquisitions granting oper - ational control, and the creation of full-function joint ventures. Parties must refrain from closing or imple - menting the transaction until formal regulatory clear - ance is explicitly granted by the authority. The regulatory review period spans up to 90 days from the submission of a complete notification file. During this period, the regulator evaluates whether the proposed transaction will create a dominant posi - tion or substantially lessen competition in the relevant market. Transactions that threaten market competi - tion may be blocked entirely or approved subject to structural or behavioural commitments. Furthermore, executing a reportable transaction without prior clear - ance exposes the participating entities to administra - tive fines and legal invalidity. The risk of post-closing transaction challenges cre - ates severe strategic exposure for corporate buyers and sellers alike. A disgruntled competitor or market participant can challenge an unapproved transac - tion in court, arguing that the concentration creates an unlawful market monopoly. If the court agrees, it possesses the legal authority to declare the transac - tion null and void, effectively ordering the unwinding of the deal. To eliminate this catastrophic risk, M&A practitioners must build rigorous antitrust clearance conditions into all transaction documentation. The protected status of small and medium enterprises A distinctive feature of Bahrain’s competition frame - work is the special legal status granted to micro, small, and medium enterprises. Recognising that smaller firms often face structural disadvantages when com - peting against established commercial giants, the law provides tailored exemptions for certain collaborative SME arrangements. Specifically, agreements between small enterprises that would otherwise violate com - petition rules may be permitted if they enhance com -
Law, the pass-on defence is recognised under gen - eral civil law principles prohibiting unjust enrichment. A defendant can argue that a direct purchaser claim - ant suffered no actual loss because the overcharge was passed down to end-consumers. The burden of proving that the claimant successfully passed on the overcharge rests entirely on the defendant asserting the defence. Sectoral hotspots: digital markets, banking, and healthcare As Bahrain’s economy modernises, specific high- growth sectors are emerging as primary hotspots for competition scrutiny and litigation. The digital econo - my and e-commerce platforms represent a prime area of regulatory focus due to rapid market concentra - tion. Digital gatekeepers leveraging network effects to favour their own proprietary services over third-party vendors face increasing legal scrutiny. As consumer transactions shift online, disputes regarding platform self-preferencing and data access are expected to multiply rapidly. The financial services and banking sector also pre - sents unique antitrust litigation risks within the King - dom. As Bahrain consolidates its position as a region - al financial hub, collaborative arrangements between financial institutions are coming under closer review. Issues such as information sharing between compet - ing lenders, fee standardisation and barriers restrict - ing fintech innovation can trigger regulatory investi - gations. Financial institutions must ensure that joint ventures and industry association activities maintain strict antitrust firewalls to avoid exposure. Similarly, the healthcare and pharmaceutical indus - tries are subjected to rigorous competition oversight due to their direct impact on public welfare. Anti-com - petitive practices in this sector, such as pay-for-delay agreements or exclusive distribution deals that artifi - cially inflate medicine prices, face severe enforcement actions. Aggrieved hospital groups, private health insurers and consumer groups are increasingly willing to challenge restrictive supply practices. Ensuring fair pricing and open distribution in healthcare remains a key policy objective for regional enforcement authori - ties.
38 A NTITRUST LI T IGATI O N 2026
CHAMBERS.COM
Powered by FlippingBook